Attract talent

Arbutus Biopharma



Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).


Add photos to showcase Arbutus Biopharma’s culture


Add Arbutus Biopharma’s values

Insider experiences

Share your experience of working at Arbutus Biopharma

William H. Collier
President & CEO
Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Gaston Picchio
Chief Development Officer
Michael J. Sofia Phd
Chief Scientific Officer

Add your teams to show how people work together at Arbutus Biopharma

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.